Innovative formulations for the ocular delivery of coenzyme Q10

Area of Science:

• Ophthalmology
• Nanotechnology
• Pharmacology

Background:

• Coenzyme Q10 (CoQ10) is a vital antioxidant for mitochondrial function.
• CoQ10's neuroprotective properties show promise for ocular neurodegenerative diseases.
• Effective delivery of CoQ10 to the posterior segment of the eye is hindered by ocular barriers.

Purpose of the Study:

• To develop novel ocular delivery strategies for CoQ10.
• To enhance CoQ10's bioavailability in the posterior segment of the eye.
• To achieve controlled release of CoQ10 for sustained therapeutic effects.

Main Methods:

• Polymeric micelles of D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) were formulated to load CoQ10.
• Micelles were characterized using dynamic light scattering (DLS) and small-angle X-ray scattering (SAXS).
• Ex vivo studies on porcine sclera and choroid assessed micelle retention and permeation.
• Loaded micelles were incorporated into a crosslinked polymer film for controlled release and biocompatibility testing (HET-CAM assay).

Main Results:

• TPGS micelles successfully loaded and increased CoQ10 solubility and ocular tissue penetration.
• Ex vivo studies demonstrated micelle retention and permeation capacity in ocular tissues.
• The polymer film provided controlled release of TPGS and CoQ10 and showed good biocompatibility.
• Ex vivo studies confirmed the potential of this ocular delivery platform.

Conclusions:

• TPGS-CoQ10 micelles represent a promising strategy for enhancing ocular bioavailability.
• The developed polymer film platform facilitates controlled release and demonstrates biocompatibility.
• This novel delivery system holds potential for treating ocular neurodegenerative diseases requiring CoQ10 therapy.